Clover Biopharmaceuticals, Ltd.
HKEX:2197.HK
0.218 (HKD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 735.864 | 735.864 | 1,264.455 | 1,264.455 | 1,607.409 | 1,607.409 | 2,255.642 | 2,255.642 | 2,767.371 | 2,767.371 | 1,828.78 |
| Short Term Investments
| 30.393 | 2.943 | 34.105 | 2.943 | 33.172 | 2.943 | 27.075 | 12.943 | 98.796 | 61.088 | 245.293 |
| Cash and Short Term Investments
| 766.257 | 752.972 | 1,298.56 | 1,281.85 | 1,640.581 | 1,624.281 | 2,282.717 | 2,268.585 | 2,866.167 | 2,859.367 | 2,074.073 |
| Net Receivables
| 24.106 | 24.106 | 0.581 | 0.581 | -13.929 | -13.929 | 0 | 0 | -30.908 | -30.908 | 0 |
| Inventory
| 696.978 | 696.978 | 1,169.058 | 1,169.058 | 2,384.34 | 2,384.34 | 1,536.471 | 1,536.471 | 768.691 | 768.691 | 146.717 |
| Other Current Assets
| 426.343 | 439.628 | 368.523 | 368.523 | 395.237 | 395.237 | 1,075.432 | 1,089.564 | 1,479.345 | 1,479.345 | 173.99 |
| Total Current Assets
| 1,899.519 | 1,899.519 | 2,805.56 | 2,805.56 | 4,389.929 | 4,389.929 | 4,894.62 | 4,894.62 | 5,076.495 | 5,076.495 | 2,394.78 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 162.056 | 162.056 | 219.036 | 219.036 | 241.744 | 241.744 | 245.303 | 245.303 | 222.403 | 222.403 | 140.723 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 39.859 | 39.859 | 36.192 | 36.192 | 34.998 | 34.998 | 25.164 | 25.164 | 13.828 | 13.828 | 6.481 |
| Goodwill and Intangible Assets
| 39.859 | 39.859 | 36.192 | 36.192 | 34.998 | 34.998 | 25.164 | 25.164 | 13.828 | 13.828 | 6.481 |
| Long Term Investments
| -14.165 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 14.165 | 0 | 18.257 | 18.257 | 28.035 | 28.035 | 47.916 | 47.916 | 32.934 | 32.934 | 28.125 |
| Total Non-Current Assets
| 201.915 | 201.915 | 273.485 | 273.485 | 304.777 | 304.777 | 318.383 | 318.383 | 269.165 | 269.165 | 175.329 |
| Total Assets
| 2,101.434 | 2,101.434 | 3,079.045 | 3,079.045 | 4,694.706 | 4,694.706 | 5,213.003 | 5,213.003 | 5,345.66 | 5,345.66 | 2,570.109 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 247.829 | 247.829 | 226.378 | 226.378 | 856.964 | 856.964 | 970.733 | 970.733 | 588.559 | 588.559 | 98.831 |
| Short Term Debt
| 326.598 | 308.063 | 433.791 | 409.952 | 317.63 | 294.06 | 26.089 | 0 | 21.48 | 0 | 7.763 |
| Tax Payables
| 3.067 | 0 | 0 | 0 | 6.284 | 0 | 0 | 0 | 5.919 | 0 | 3.056 |
| Deferred Revenue
| 1,702.051 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.056 |
| Other Current Liabilities
| 0.525 | 1,721.111 | 1,707.144 | 1,730.983 | 1,654.611 | 1,678.181 | 1,612.777 | 1,638.866 | 1,538.07 | 1,559.55 | 48.395 |
| Total Current Liabilities
| 2,277.003 | 2,277.003 | 2,367.313 | 2,367.313 | 2,829.205 | 2,829.205 | 2,609.599 | 2,609.599 | 2,148.109 | 2,148.109 | 158.045 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 7.853 | 7.853 | 22.152 | 22.152 | 36.738 | 36.738 | 54.127 | 54.127 | 46.44 | 46.44 | 21.336 |
| Deferred Revenue Non-Current
| 44.364 | 0 | 145.776 | 0 | 2,496.9 | 0 | 2,372.691 | 0 | 1,931.963 | 0 | 1,210.881 |
| Deferred Tax Liabilities Non-Current
| -44.364 | 0 | 0 | 0 | -2,496.9 | 0 | -2,372.691 | 0 | -1,931.963 | 0 | 0 |
| Other Non-Current Liabilities
| 549.411 | 549.411 | 515.251 | 661.027 | 2,496.9 | 2,496.9 | 2,372.691 | 2,372.691 | 1,931.963 | 1,931.963 | 3,063.343 |
| Total Non-Current Liabilities
| 557.264 | 557.264 | 683.179 | 683.179 | 2,533.638 | 2,533.638 | 2,426.818 | 2,426.818 | 1,978.403 | 1,978.403 | 4,295.56 |
| Total Liabilities
| 2,834.267 | 2,834.267 | 3,050.492 | 3,050.492 | 5,362.843 | 5,362.843 | 5,036.417 | 5,036.417 | 4,126.512 | 4,126.512 | 4,453.605 |
| Equity: | |||||||||||
| Preferred Stock
| 9,640.268 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6,753.194 | 0 | 0 |
| Common Stock
| 0.838 | 0.838 | 0.836 | 0.836 | 0.835 | 0.835 | 0.744 | 0.744 | 0.742 | 0.742 | 0.033 |
| Retained Earnings
| -9,640.268 | -9,640.268 | -8,851.105 | -8,851.105 | -9,501.729 | -9,501.729 | -8,185.911 | -8,185.911 | -7,049.826 | -7,049.826 | 0 |
| Accumulated Other Comprehensive Income/Loss
| -733.641 | 285.85 | 290.218 | 290.218 | 270.383 | 270.383 | 301.321 | 301.321 | 296.632 | 296.632 | -982.741 |
| Other Total Stockholders Equity
| -0.03 | 8,620.747 | 8,588.604 | 8,588.604 | 8,562.374 | 8,562.374 | 8,060.432 | 8,060.432 | 1,218.406 | 7,971.6 | -900.788 |
| Total Shareholders Equity
| -732.833 | -732.833 | 28.553 | 28.553 | -668.137 | -668.137 | 176.586 | 176.586 | 1,219.148 | 1,219.148 | -1,883.496 |
| Total Equity
| -732.833 | -732.833 | 28.553 | 28.553 | -668.137 | -668.137 | 176.586 | 176.586 | 1,219.148 | 1,219.148 | -1,883.496 |
| Total Liabilities & Shareholders Equity
| 2,101.434 | 2,101.434 | 3,079.045 | 3,079.045 | 4,694.706 | 4,694.706 | 5,213.003 | 5,213.003 | 5,345.66 | 5,345.66 | 2,570.109 |